{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:41:11Z","timestamp":1752982871589},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00115-004-1820-6","type":"journal-article","created":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T12:02:34Z","timestamp":1095854554000},"page":"617-622","source":"Crossref","is-referenced-by-count":9,"title":["Depression bei Hashimoto-Enzephalopathie"],"prefix":"10.1007","volume":"76","author":[{"given":"C.","family":"Laske","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Leyhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Buchkremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wormstall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1820_CR1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/archneur.60.2.164","volume":"60","author":"Chong","year":"2003","unstructured":"Chong JY, Rowland LP, Utiger RD (2003) Hashimoto encephalopathy: syndrome or myth? Arch Neurol 60:164\u2013171","journal-title":"Arch Neurol"},{"key":"1820_CR2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s001150050613","volume":"71","author":"Hartmann","year":"2000","unstructured":"Hartmann M, Schaner B, Scheglmann K et al. (2000) Hashimoto-Enzephalopathie: Steroid-sensitive Enzephalopathie bei Hashimoto-Thyreoiditis. Nervenarzt 71:489\u2013494","journal-title":"Nervenarzt"},{"key":"1820_CR3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1037\/0033-2909.113.3.472","volume":"113","author":"Herbert","year":"1993","unstructured":"Herbert TB, Cohen S (1993) Depression and immunity: a meta-analytic review. Psychol Bull 113:472\u2013486","journal-title":"Psychol Bull"},{"key":"1820_CR4","unstructured":"Herold G et al. (2000) Innere Medizin. Herold, K\u00f6ln, S\u00a0619"},{"key":"1820_CR5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/thy.1996.6.63","volume":"6","author":"Jackson","year":"1996","unstructured":"Jackson IM (1996) Does thyroid hormone have a role as adjunctive therapy in depression? Thyroid 6:63\u201367","journal-title":"Thyroid"},{"key":"1820_CR6","first-page":"1469","volume":"46","author":"Klein","year":"1992","unstructured":"Klein JF (1992) Adverse psychiatric effects of systemic glucocorticoid therapy. Am Fam Physician 46:1469\u20131474","journal-title":"Am Fam Physician"},{"key":"1820_CR7","first-page":"126","volume":"26","author":"K","year":"1999","unstructured":"K\u00f6nig F, von Hippel C, Petersdorff T et al. (1999) Thyroid autoantibodies in depressive disorders. Acta Med Austriaca 26:126\u2013128","journal-title":"Acta Med Austriaca"},{"key":"1820_CR8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00900946","volume":"243","author":"Kothbauer-Margreiter","year":"1996","unstructured":"Kothbauer-Margreiter I, Sturzenegger M, Komor J et al. (1996) Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 243:585\u2013593","journal-title":"J Neurol"},{"key":"1820_CR9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/eje.0.1450579","volume":"145","author":"Kuijpens","year":"2001","unstructured":"Kuijpens JL, Vader HL, Drexhage HA et al. (2001) Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. Eur J Endocrinol 145:579\u2013584","journal-title":"Eur J Endocrinol"},{"key":"1820_CR10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0736-5748(01)00014-4","volume":"19","author":"Leonard","year":"2001","unstructured":"Leonard BE (2001) Changes in the immune system in depression and dementia: causal or co-incidental effects? Int J Dev Neurosci 19:305\u2013312","journal-title":"Int J Dev Neurosci"},{"key":"1820_CR11","unstructured":"Muller N, Ackenheil M, Hofschuster E (1989) Altered T-cell number and reduced suppressor cell activity in patients with affective psychosis. In: Hadden JW, Masek K, Nistico G (eds) Interactions among central nervous system. Neuroendocrine and immune systems. Pythagora Press, Rome, pp\u00a0385\u2013394"},{"key":"1820_CR12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0212-6567(00)78637-9","volume":"26","author":"Munoz-Cruzado-Poce","year":"2000","unstructured":"Munoz-Cruzado-Poce MJ, Garcia-Navas AJ, Moreno-Gomez ML et al. (2000) Prevalence of thyroid disorders in patients diagnosed with depression. Aten Primaria 26:176\u2013179","journal-title":"Aten Primaria"},{"key":"1820_CR13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1176\/ajp.142.7.840","volume":"142","author":"Nemeroff","year":"1985","unstructured":"Nemeroff CB, Simon JS, Haggerty JJ Jr. et al. (1985) Antithyroid antibodies in depressed patients. Am J Psychiatry 142:840\u2013843","journal-title":"Am J Psychiatry"},{"key":"1820_CR14","first-page":"444","volume":"96","author":"Ohashi","year":"1994","unstructured":"Ohashi Y (1994) The baseline EEG traits and the induced EEG changes by chronic antidepressant medication in patients with major depression. Early prediction of clinical outcomes solely based on quantification and mapping of EEG. Seishin Shinkeigaku Zasshi 96:444\u2013460","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"1820_CR15","first-page":"36","volume":"Endocrinol","author":"Pedersen","year":"2003","unstructured":"Pedersen IB, Knudsen N, Jorgensen T et al. (2003) Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf) 58:36\u201342","journal-title":"Clin"},{"key":"1820_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1469-8986.1990.tb02340.x","volume":"27","author":"Pollock","year":"1990","unstructured":"Pollock, VE, Schneider LS (1990) Topographic quantitative EEG in elderly subjects with major depression. Psychophysiology 27:438\u2013444","journal-title":"Psychophysiology"},{"key":"1820_CR17","first-page":"3194","volume":"83","author":"Pop","year":"1998","unstructured":"Pop VJ, Maartens LH, Leusink G et al. (1998) Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab 83:3194\u20133197","journal-title":"J Clin Endocrinol Metab"},{"key":"1820_CR18","first-page":"137","volume":"27","author":"Rolland","year":"2001","unstructured":"Rolland F, Chevrollier JP (2001) Depression, anti-thyroid antibodies and Hashimoto encephalopathy. Encephale 27:137\u2013142","journal-title":"Encephale"},{"key":"1820_CR19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1388-2457(02)00343-7","volume":"114","author":"Schauble","year":"2003","unstructured":"Schauble B, Castillo PR, Boeve BF et al. (2003) EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 114:32\u201337","journal-title":"Clin Neurophysiol"},{"key":"1820_CR20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0447.1996.tb09849.x","volume":"94","author":"Seidel","year":"1996","unstructured":"Seidel A, Arolt V, Hunstiger M et al. (1996) Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand 94:198\u2013204","journal-title":"Acta Psychiatr Scand"},{"key":"1820_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/clin.1996.0012","volume":"78","author":"Seidel","year":"1996","unstructured":"Seidel A, Arolt V, Hunstiger M et al. (1996) Increased CD56+ natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 78:83\u201385","journal-title":"Clin Immunol Immunopathol"},{"key":"1820_CR22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jnnp.66.2.172","volume":"66","author":"Seipelt","year":"1999","unstructured":"Seipelt M, Zerr I, Nau R et al. (1999) Hashimoto\u2019s encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 66:172\u2013176","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1820_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-1781(96)02783-7","volume":"64","author":"Sluzewska","year":"1996","unstructured":"Sluzewska A, Rybakowski J, Bosmans E et al. (1996) Indicators of immune activation in major depression. Psychiatry Res 64:161\u2013167","journal-title":"Psychiatry Res"},{"key":"1820_CR24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1191\/1352458503ms915oa","volume":"9","author":"Zephir","year":"2003","unstructured":"Zephir H, De Seze J, Stojkovic T et al. (2003) Multiple sclerosis and depression: influence of interferon beta therapy. Mult Scler 9:284\u2013288","journal-title":"Mult Scler"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-004-1820-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-004-1820-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-004-1820-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:00:44Z","timestamp":1558573244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-004-1820-6"}},"subtitle":["Erfolgreiche Behandlung einer schweren depressiven Episode mit einem Kortikosteroid als Add-on-Therapie"],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["1820"],"URL":"https:\/\/doi.org\/10.1007\/s00115-004-1820-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}